Evolution of Plasmid-Mediated Antibiotic Resistance in the Clinical Context

Area of Science:

• Microbiology
• Evolutionary Biology
• Clinical Medicine

Background:

• Antibiotic-resistant infections pose a significant threat in clinical settings, elevating mortality rates in critically ill patients.
• The horizontal transfer of antibiotic resistance genes, primarily through bacterial plasmids, accelerates the evolution and spread of resistance.
• Specific associations between resistance plasmids and successful bacterial clones in clinical environments are observed, but the underlying reasons are unclear.

Purpose of the Study:

• To investigate the factors contributing to the clinical success of specific bacteria-plasmid associations.
• To explore the role of plasmid-imposed fitness costs and compensatory mutations in shaping antibiotic resistance evolution in vivo.

Main Methods:

• The study synthesizes recent in vitro findings on plasmid-mediated fitness costs and compensatory adaptation in bacteria.
• It proposes a theoretical framework to explain the in vivo success of bacteria-plasmid associations.

Main Results:

• Plasmids can impose fitness costs on their host bacteria.
• These costs are often alleviated over time through the acquisition of compensatory mutations.
• These dynamics may be critical in determining the success of bacteria-plasmid associations in clinical settings.

Conclusions:

• Plasmid-imposed fitness costs and subsequent compensatory evolution are hypothesized to be key drivers of successful bacteria-plasmid associations.
• This interplay likely shapes the in vivo evolution and dissemination of antibiotic resistance in clinical environments.
• Understanding these mechanisms is crucial for combating the growing threat of antibiotic resistance.